Citation: L. Cashinhemphill, HORMONE-REPLACEMENT THERAPY COMPARED WITH SIMVASTATIN FOR POSTMENOPAUSAL WOMEN WITH HYPERCHOLESTEROLEMIA (VOL 338, PG 63, 1998), The New England journal of medicine, 338(13), 1998, pp. 931-931
Citation: L. Cashinhemphill et Li. Vailas, HORMONE-REPLACEMENT THERAPY COMPARED WITH SIMVASTATIN FOR POSTMENOPAUSAL WOMEN WITH HYPERCHOLESTEROLEMIA, The New England journal of medicine, 338(1), 1998, pp. 63-63
Authors:
CASHINHEMPHILL L
DINSMORE RE
CHAN RC
WILLIAMS SN
HOLMVANG G
HABER HE
LEES RS
Citation: L. Cashinhemphill et al., ATHEROSCLEROSIS PROGRESSION IN SUBJECTS WITH AND WITHOUT POSTANGIOPLASTY RESTENOSIS IN QUIET, Journal of the American College of Cardiology, 29(2), 1997, pp. 3870-3870
Authors:
CASHINHEMPHILL L
DINSMORE RE
CHAN RC
WILLIAMS SN
HOLMVANG G
HABER HE
LEES RS
Citation: L. Cashinhemphill et al., LDL CHOLESTEROL AND ANGIOGRAPHIC PROGRESSION IN THE QUIET TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 7251-7251
Authors:
LEES RS
PITT B
CHAN RC
HOLMVANG G
DINSMORE RE
CAMPBELL LW
HARBER HE
KLIBANER MI
CASHINHEMPHILL L
Citation: Rs. Lees et al., BASE-LINE CLINICAL AND ANGIOGRAPHIC DATA IN THE QUINAPRIL ISCHEMIC EVENT (QUIET) TRIAL, The American journal of cardiology, 78(9), 1996, pp. 1011-1016
Authors:
HODIS HN
MACK WJ
LABREE L
CASHINHEMPHILL L
SEVANIAN A
JOHNSON R
AZEN SP
Citation: Hn. Hodis et al., SERIAL CORONARY ANGIOGRAPHIC EVIDENCE THAT ANTIOXIDANT VITAMIN INTAKEREDUCES PROGRESSION OF CORONARY-ARTERY ATHEROSCLEROSIS, JAMA, the journal of the American Medical Association, 273(23), 1995, pp. 1849-1854
Authors:
ALAUPOVIC P
HODIS HN
KNIGHTGIBSON C
MACK WJ
LABREE L
CASHINHEMPHILL L
CORDER CN
KRAMSCH DM
BLANKENHORN DH
Citation: P. Alaupovic et al., EFFECTS OF LOVASTATIN ON APOA-CONTAINING AND APOB-CONTAINING LIPOPROTEINS - FAMILIES IN A SUBPOPULATION OF PATIENTS PARTICIPATING IN THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS), Arteriosclerosis and thrombosis, 14(12), 1994, pp. 1906-1914
Authors:
MILLER BD
CASHINHEMPHILL L
MACK WJ
HODIS HN
KRAUSS RM
Citation: Bd. Miller et al., PREDOMINANCE OF MID-DENSITY LOW-DENSITY LIPOPROTEINS PREDICTS ANGIOGRAPHIC BENEFIT OF LOVASTATIN IN THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY, Circulation, 90(4), 1994, pp. 460-460
Authors:
MILLER BD
CASHINHEMPHILL L
MACK WJ
HODIS HN
KRAUSS RM
Citation: Bd. Miller et al., PREDOMINANCE OF MID-DENSITY LOW-DENSITY LIPOPROTEINS PREDICTS ANGIOGRAPHIC BENEFIT OF LOVASTATIN IN THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY, Circulation, 90(4), 1994, pp. 460-460
Citation: Hn. Hodis et al., EFFECTS OF LOVASTATIN AND PRAVASTATIN ON CORONARY-ARTERY DISEASE - REPLY, Annals of internal medicine, 120(9), 1994, pp. 812-812
Authors:
MILLER BD
KRAUSS RM
CASHINHEMPHILL L
BLANKENHORN DH
Citation: Bd. Miller et al., BASE-LINE TRIGLYCERIDE LEVELS PREDICT ANGIOGRAPHIC BENEFIT OF COLESTIPOL PLUS NIACIN THERAPY IN THE CHOLESTEROL-LOWERING ATHEROSCLEROSIS STUDY (CLAS), Circulation, 88(4), 1993, pp. 363-363
Authors:
BLANKENHORN DH
AZEN SP
KRAMSCH DM
MACK WJ
CASHINHEMPHILL L
HODIS HN
DEBOER LWV
MAHRER PR
MASTELLER MJ
VAILAS LI
ALAUPOVIC P
HIRSCH LJ
Citation: Dh. Blankenhorn et al., CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITOREDATHEROSCLEROSIS REGRESSION STUDY (MARS), Annals of internal medicine, 119(10), 1993, pp. 969-976